Biotech startups face ‘Series A cliff’ as venture capital stays cautious

cafead

Administrator
Staff member
  • cafead   Mar 24, 2023 at 10:22: AM
via Series A rounds have been easy to secure in the last few years, but industry watchers say they haven’t seen a corresponding increase in Series B’s.

article source
 

<